Pharmaceuticals Sector

Related Search

Blogs
May 10, 2006
MoveOn vs. Rohrabacher
This just in, from MoveOn.org: Rep. Rohrabacher Accepts $40,785.00 From Drug Companies; Puts Drug Company Profits Ahead of Seniors Huntington Beach MoveOn Members Urge Rep. Dana Rohrabacher to Cancel May 15th Medicare Sign-Up Deadline Constituents will hold "Caught Red-Handed Check Deliveries" out ... More >>
Blogs
October 7, 2010
Judge Greenlights $600 Million Fine Against Irvine-Based Maker of Botox
Allergan, Inc.'s misleading marketing cost them big time. A judge this week approved the $600 million fine feds previously announced against the Irvine-based pharmaceutical company whose most popular product is Botox. But don't cry too hard for Allergan: Botox earns the company $1.3 billion in an ... More >>
Blogs
October 26, 2010
Got Migraines? Try Botox, Says Irvine Drugmaker
There's some good news and bad news for Allergan, Inc. Bad news: The Irvine-based pharmaceutical company tops the list of Department of Justice fraud settlements in the 2010 fiscal year, having lost $600 million in an October lawsuit that accused them of marketing Botox for "off-label" uses.Good ... More >>
Blogs
May 13, 2011
Allergan PR Campaign Pays Off Reporters
An Allergan public relations campaign is being called "sleazy."A PR company working for the Irvine-based pharmaceutical giant is apparently offering journalists $250 to attend an Allergan-sponsored media presentation on Botox, Latisse and Juvederm.
Blogs
May 25, 2011
Allergan Wants The FDA To Approve Lap-Bands For Teens
In another attempt to expand the fatty pool for its popular Lap-Band devices, Allergan Inc. is now targeting a younger set. The Irvine-based pharmaceutical company has asked the Food and Drug Administration to allow the weight-loss surgery for those as young as 14, the Los Angeles Times rep ... More >>
Blogs
January 17, 2012
[UPDATE: Paula Explains on Today] Paula Deen Is Diabetic -- and Cashing In
UPDATE, JAN. 17, 9:30 A.M. In this morning's appearance on The Today Show, Deen clears up a few details. She's a paid spokesperson for Novo Nordisk, not Novartis. Al Roker lobbed a few pointed questions, and Deen revealed she kept her diagnosis from the public for three years whi ... More >>